Loading...

Francisco Grilo, MD

Breast Imaging

Higher Education
  • Master's Degree in Medicine, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto (2012–2018).
  • Final grade: 17/20.
Postgraduate Education
  • General Medical Training, Unidade Local de Saúde de Matosinhos (2019).
  • Radiology Residency, Unidade Local de Saúde de Braga (2020–2024).
  • Final grade: 18.26/20.
  • Advanced training in Breast Imaging: four months at ULS Braga and three months at Instituto Português de Oncologia de Lisboa, covering mammography, ultrasound, breast MRI, image-guided biopsies and preoperative localisation procedures (2024).
  • European Diploma in Radiology (EDiR) (2025).
Previous Medical and Scientific Jobs
  • General Medical Trainee, Unidade Local de Saúde de Matosinhos (2019).
  • Radiology Resident, Unidade Local de Saúde de Braga (2020–2024); Chief Resident in 2024.
  • Guest Lecturer, School of Medicine, University of Minho, in the 2021/2022 and 2022/2023 academic years, teaching introductory imaging techniques and clinical/academic practice.
  • Active contributor to the multidisciplinary team meetings (MDTs) in Breast Cancer at ULS Braga.
  • Attended 35 radiology congresses, courses and training activities during residency: 18 international and 17 national, namely:
  • European Society of Breast Imaging (EUSOBI)’s Breast MRI course (2023).
  • Dutch Expert Screening Centre (LRCB)’s Breast screening course (2024).
  • Author or co-author of 13 scientific publications: four articles in indexed journals (two as first author and two as co-author) and nine articles in non-indexed journals (three as first author and six as co-author). Also served as a reviewer for a radiology article submitted to Acta Médica Portuguesa.
Present Job
  • Attending Radiologist at Unidade Local de Saúde de Braga, with a particular focus on breast imaging and involvement in diagnostic imaging, image-guided procedures and multidisciplinary care.
Participation in Research Projects
  • Investigator in two institutional Breast Cancer clinical trials at ULS Braga, in collaboration with the 2CA Clinical Centre:
  • CAMBRIA-1
  • DESTINY-Breast15